InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Hrynkow Sharon Hemond, Directeur Scientifique. Director active across 1 companies, notably Cyclo Therapeutics, Inc.. In total, 2 disclosures have been published. Total volume traded: €9k. The latest transaction was disclosed on 2 December 2021 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€4,3991,000 shares@ €4.3995100.0% of flow
Common Stock
SEC:0001437749-21-027716·
Ideal exit: 29 Aug 2022 (T+270)
€4,3991,000 shares@ €4.399550.0% of flow
Common Stock
SEC:0001437749-21-027716:0·
Ideal exit: 29 Aug 2022 (T+270)
2 of 2 declarations
About Hrynkow Sharon Hemond
Hrynkow Sharon Hemond is the Chief Scientific Officer of Cyclo Therapeutics, Inc. She is responsible for leading the company's research and development initiatives. Her role involves overseeing scientific projects and ensuring that research objectives are met. With extensive expertise in her field, she plays a key role in the innovation of the company's products.
